Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Zota Health Care
Small Cap•445 Employees•IPO 2017
Current Price
₹1219.40
4.3 (0.35%)Updated
Today's Range
₹1174.00
₹1241.90
₹1219.40
52 Week Range
52W Low₹752.00
52W High₹1740.00
₹1219.40
Downside62.15%
Upside42.69%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹4,532.65 Cr
Market Cap
Total market value of companyP/E Ratio
-
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
13.66
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹-23.98
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-10.69%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
-17.00%
ROCE
Return on Capital Employed. >15% is goodNet Margin
-15.37%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
25.23%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
91.70%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-31.80%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.62
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹78.12
Book Value
Net asset value per shareDividend Yield
0.06%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
57.40%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Robust 91.70% quarterly sales growth indicates strong top-line expansion.
- •Substantial 57.4% promoter holding signals strong insider confidence and commitment.
Weaknesses
5 points- •Consistent negative net profits (PAT -61.8 Cr) raise significant sustainability concerns.
- •Deeply negative ROE (-36.00%) and ROCE (-17.00%) indicate inefficient capital utilization.
Opportunities
5 points- •Healthcare sector, especially pharmaceuticals, offers inherent global demand growth opportunities.
- •Relatively small market cap (4719 Cr) allows substantial market share expansion.
Threats
5 points- •Intense competition from established players like Sun Pharma limits market share.
- •Heavy pharmaceutical industry regulation; policy changes could negatively impact operations/profitability.
Segment-wise Financial Analysis
Financial Results
Balance Sheet
Standalone • Annual • All amounts in ₹ Crores • CA Schedule III Format
No Balance Sheet Data Available
Standalone annual data is not available for this symbol.
Try switching to Consolidated view.
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
Recent Insider Transactions
| Insider Name | Transaction Date | Filing Date | Total Shares | Change | Price | Action |
|---|---|---|---|---|---|---|
VINODCHANDRA DHIRAJLAL MEHTA | 20 Dec 2024 | 24 Dec 2024 | 4,399 | 2,000 | ₹780.61 | SELL |
NIRUBEN VINODKUMAR MEHTA | 02 Dec 2024 | 24 Dec 2024 | - | 6,072 | ₹608.5 | SELL |
VINODCHANDRA DHIRAJLAL MEHTA | 02 Dec 2024 | 24 Dec 2024 | 6,399 | 6,072 | ₹608.5 | BUY |
KENVI ZOTA | 17 Mar 2025 | 18 Mar 2025 | 95,000 | 95,000 | ₹774.45 | BUY |
HIMANSHU MUKTILAL ZOTA | 17 Mar 2025 | 18 Mar 2025 | 31.36 L | 97,200 | ₹774.67 | SELL |
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹1385.33 | +₹165.93 | +13.61% |
| R3 | ₹1317.43 | +₹98.03 | +8.04% |
| R2 | ₹1279.67 | +₹60.27 | +4.94% |
| R1 | ₹1249.53 | +₹30.13 | +2.47% |
| PIVOT | ₹1211.77 | -7.63 | -0.63% |
| CURRENT | ₹1219.40 | - | - |
| S1 | ₹1045.83 | -₹173.57 | -14.23% |
| S2 | ₹1113.73 | -₹105.67 | -8.67% |
| S3 | ₹1143.87 | -₹75.53 | -6.19% |
| S4 | ₹1181.63 | -₹37.77 | -3.10% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume-21.0% vs avg
0.35L
(02 Mar 2026)Delivery %-9.8% vs avg
45.3%
(02 Mar 2026)Avg Volume (20D)20-day average
0.44L
(03 Feb - 02 Mar)Avg Delivery %Trend ↓
55.1%
(03 Feb - 02 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Sun Pharmaceutical Industries Ltd
4.12L ₹ Cr
Best Profit Growth
Shilpa Medicare Ltd
234.00 %
Highest Dividend Yield
RPG Life Sciences Ltd
1.22 %
Peer Comparison
| Company Name |
|---|
 Aarti Drugs Ltd |
 Aarti Pharmalabs Ltd |
 Blue Jet Healthcare Ltd |
 FDC Ltd |
 Gufic BioSciences Ltd |
 Orchid Pharma Ltd |
 RPG Life Sciences Ltd |
 Senores Pharmaceuticals Ltd |
 Sequent Scientific Ltd |
 Shilpa Medicare Ltd |
 SMS Pharmaceuticals Ltd |
 Sun Pharma Advanced Research Company Ltd |
 Sun Pharmaceutical Industries Ltd |
 Supriya Lifescience Ltd |
 Unichem Laboratories Ltd |
About
Zota Health Care Ltd
Zota Health Care Limited is a pharmaceutical company headquartered in Surat, India, established in 1995. Its core business revolves around the development, manufacturing, and marketing of a diverse range of pharmaceutical products both domestically within India and internationally.
The company's product portfolio is extensive and caters to a broad spectrum of healthcare needs. This includes a significant presence in the generic drug market, offering affordable alternatives to branded medications. Beyond generics, Zota also manufactures and markets wellness products, over-the-counter (OTC) medications readily available without a prescription, and products rooted in traditional Ayurvedic medicine and the increasingly popular nutraceutical sector. This diversified approach allows them to tap into various segments of the healthcare market.
A key focus for Zota is addressing chronic illnesses prevalent globally. Their product line specifically includes medications designed to manage and treat conditions such as diabetes, heart disease, and thyroid disorders. This concentration on chronic care highlights a commitment to providing essential therapies for long-term health management.
In addition to its wholesale and export operations, Zota also has a retail presence in India. Operating under the brand name DAVAINDIA, these retail stores provide a direct-to-consumer channel for the company's products, enhancing brand visibility and facilitating direct customer engagement.
In summary, Zota Health Care Limited is a multifaceted pharmaceutical company with a substantial presence in India and international markets. Its strategic diversification across various product categories, including generics, wellness, OTC, Ayurvedic, and nutraceutical products, coupled with its retail and export operations, positions it for continued growth and success in the dynamic healthcare industry.
COMPANY FACTS - ZOTA
Registered Address
Zota House 2/896, Hira Modi Street Sagrampura
Surat
GUJARAT
IN
Tel: 912612331601
Website:https://www.zotahealthcare.com/
Investor Relations:http://www.zotahealthcare.com/investorrelations/financial-results/
Company Details
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 445
IPO Date: 10/05/2017
MANAGEMENT - ZOTA
Mr. Ketankumar Zota
Non-Executive Chairman of the Board
Mr. Viral Mandviwala
Chief Financial Officer
Mr. Ashvin Variya
Compliance Officer, Company Secretary
Mr. Moxesh Zota
Executive Managing Director
Mr. Laxmi Sharma
Executive Director
Mr. Himanshu Zota
Executive Whole-time Director
Mr. Kamlesh Zota
Executive Whole-time Director
Mr. Viren Zota
Whole-Time Director, Head of Domestic Market
Mr. Ratilal Harkhani
Plant Manager
Mr. Niralkumar Zota
Head of Domestic Market
Mrs. Bhumi Doshi
Non-Executive Independent Director
Mrs. Jayshreeben Mehta
Non-Executive Independent Director
Investor Questions Answered
Zota Health Care Ltd (ZOTA) Stock FAQs
Get answers to the most common questions about Zota Health Care Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Zota Health Care Ltd (ZOTA) is ₹1,219.4. Today, the stock has gained by ₹4.30 (0.35%), trading in a range of ₹1,174 to ₹1,241.9. The stock opened at ₹1,200 with a trading volume of 34,827 shares.
Zota Health Care Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,532.65 crores, P/E ratio of 0.00, ROE of -10.69%, and ROCE of -17.00%. The dividend yield stands at 0.06%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Zota Health Care Ltd (ZOTA) is ₹1,740, while the 52-week low is ₹752. Currently trading at ₹1,219.4, the stock is 47.3% away from its 52-week low and 29.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Zota Health Care Ltd stock at ₹1,219.4 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of N/A. Today's performance shows a gain of 0.35%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Zota Health Care Ltd offers a dividend yield of 0.06%, which means for every ₹100 invested at the current price of ₹1,219.4, you can expect to receive approximately ₹0.06 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Zota Health Care Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: N/A, ROE: -10.69%, ROCE: -17.00%, Dividend Yield: 0.06%, EPS: ₹-23.98, Book Value: ₹78.12, Debt-to-Equity: 0.62, and Current Ratio: N/A. The company's market cap stands at ₹4,532.65 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Zota Health Care Ltd stock opened at ₹1,200 and is currently trading at ₹1,219.4, showing a gain of ₹4.30 (0.35%). The intraday high is ₹1,241.9 and low is ₹1,174. The trading volume stands at 34,827 shares, indicating moderate market participation today.
Zota Health Care Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-23.98, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
Zota Health Care Ltd has a market capitalization of ₹4,532.65 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹1,219.4) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Zota Health Care Ltd has a book value of ₹78.12 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹1,219.4, which is 1460.9% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Zota Health Care Ltd has a Return on Equity (ROE) of -10.69% and Return on Capital Employed (ROCE) of -17.00%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Zota Health Care Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Zota Health Care Ltd has a debt-to-equity ratio of 0.62, which measures the company's financial leverage by comparing total debt to shareholders' equity. This moderate ratio indicates balanced use of debt and equity. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Zota Health Care Ltd has an Earnings Per Share (EPS) of ₹-23.98, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹1,219.4 and P/E ratio of 0.00, investors are paying 0.00 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Zota Health Care Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Zota Health Care Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Zota Health Care Ltd stock, consider: 1) Fundamental Analysis - Review P/E (0.00), ROE (-10.69%), debt-to-equity (0.62), and growth rates. 2) Technical Analysis - Check 52-week range (₹752.00 - ₹1740.00), moving averages, and chart patterns. 3) Valuation - Compare current price (₹1219.40) with book value (₹78.12) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Zota Health Care Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹1,219.4 is 12094x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Zota Health Care Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹752.00 - ₹1740.00). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.62 indicates leverage. 4) Liquidity Risk - Based on trading volume of 34,827 shares. 5) Valuation Risk - P/E of 0.00 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Zota Health Care Ltd operates in the industry with key metrics: P/E ratio of 0.00, ROE of -10.69%, market cap of ₹4,532.65 crores, and dividend yield of 0.06%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.62), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Zota Health Care Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹1,219.4, with a 52-week range of ₹752.00 to ₹1740.00. Based on fundamentals like P/E (0.00), ROE (-10.69%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Zota Health Care Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹1219.40. 2) Fundamental Deterioration - Declining ROE (currently -10.69%), increasing debt (D/E: 0.62), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Zota Health Care Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.06%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu